首页 > 最新文献

OTO Open最新文献

英文 中文
Comparing Satisfaction Among Providers Treating Both Pediatric and Adult Otolaryngology Patients. 比较儿科和成人耳鼻喉科医生的满意度。
IF 1.5 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-05-03 eCollection Date: 2024-04-01 DOI: 10.1002/oto2.141
Emily Y Huang, Ryan Park, Erica Park, Matthew A Firpo, Albert H Park

Objective: Although pediatric otolaryngology providers are reported to garner lower patient satisfaction than adults, this difference is not well characterized. This study investigates whether patient satisfaction differences exist in providers who treat both pediatric and adult patients.

Study design: Retrospective review.

Setting: Tertiary medical center.

Methods: In this cross-sectional study, Press Ganey surveys (PGS) completed by patients or parents on their first-time visit with 5 general otolaryngology providers from July 2014 to March 2022 were analyzed. Surveys were categorized by child (<18 years old) or adult and consisted of 14 items including 6 service domains of access, visit, nursing, provider, personal issues, and assessment. Analysis was performed with Walsh's t test and analysis of variance. Multivariable logistic regression, controlling for wait times and provider, evaluated the likelihood of highest satisfaction scores (HI-SCORES) based on age.

Results: A total of 2549 patients (135 pediatric, 2414 adults) completed the PGS on their initial visit. There was no significant difference in the mean overall satisfaction scores between pediatric and adult patients. Further analysis of service domains among pediatric patients found the mean score in the access domain to be higher for the 6- to 11-year-old age group (0-5 years old: 85.5 ± 20.5 [mean ± SD], 6-11 years old: 94.7 ± 11.5, 12-17 years old: 87.3 ± 15.4, P = .03). Pediatric patients did not have a significantly higher likelihood (odds ratio = 1.1, 95% confidence interval: 0.8-1.6, P > .05) of reporting HI-SCORES compared to adults after covariate adjustment.

Conclusion: There was no significant difference in patient satisfaction scores for providers who treat pediatric and adult patients utilizing the same facility and scheduling team.

目的:尽管有报道称儿科耳鼻喉科医生获得的患者满意度低于成人,但这种差异并没有得到很好的描述。本研究调查了同时治疗儿科和成人患者的医疗机构是否存在患者满意度差异:研究设计:回顾性研究:地点:三级医疗中心:在这项横断面研究中,我们分析了患者或家长在 2014 年 7 月至 2022 年 3 月期间首次就诊于 5 家普通耳鼻喉科医疗机构时填写的 Press Ganey 调查问卷(PGS)。调查按儿童分类(t 检验和方差分析)。在控制等待时间和医疗服务提供者的情况下,多变量逻辑回归评估了基于年龄的最高满意度得分(HI-SCORES)的可能性:共有 2549 名患者(135 名儿童,2414 名成人)在首次就诊时完成了 PGS。儿科和成人患者的平均总体满意度得分没有明显差异。对儿科患者服务领域的进一步分析发现,6-11 岁年龄组患者在就诊领域的平均得分更高(0-5 岁:85.5 ± 20.5 [平均值 ± SD],6-11 岁:94.7 ± 11.5,12-17 岁:87.3 ± 15.4,P = .03)。经协变量调整后,儿科患者报告 HI-SCORES 的可能性(几率比 = 1.1,95% 置信区间:0.8-1.6,P > .05)并未明显高于成人:结论:使用相同设施和调度团队治疗儿科和成人患者的医疗服务提供者在患者满意度评分方面没有明显差异。
{"title":"Comparing Satisfaction Among Providers Treating Both Pediatric and Adult Otolaryngology Patients.","authors":"Emily Y Huang, Ryan Park, Erica Park, Matthew A Firpo, Albert H Park","doi":"10.1002/oto2.141","DOIUrl":"https://doi.org/10.1002/oto2.141","url":null,"abstract":"<p><strong>Objective: </strong>Although pediatric otolaryngology providers are reported to garner lower patient satisfaction than adults, this difference is not well characterized. This study investigates whether patient satisfaction differences exist in providers who treat both pediatric and adult patients.</p><p><strong>Study design: </strong>Retrospective review.</p><p><strong>Setting: </strong>Tertiary medical center.</p><p><strong>Methods: </strong>In this cross-sectional study, Press Ganey surveys (PGS) completed by patients or parents on their first-time visit with 5 general otolaryngology providers from July 2014 to March 2022 were analyzed. Surveys were categorized by child (<18 years old) or adult and consisted of 14 items including 6 service domains of access, visit, nursing, provider, personal issues, and assessment. Analysis was performed with Walsh's <i>t</i> test and analysis of variance. Multivariable logistic regression, controlling for wait times and provider, evaluated the likelihood of highest satisfaction scores (HI-SCORES) based on age.</p><p><strong>Results: </strong>A total of 2549 patients (135 pediatric, 2414 adults) completed the PGS on their initial visit. There was no significant difference in the mean overall satisfaction scores between pediatric and adult patients. Further analysis of service domains among pediatric patients found the mean score in the access domain to be higher for the 6- to 11-year-old age group (0-5 years old: 85.5 ± 20.5 [mean ± SD], 6-11 years old: 94.7 ± 11.5, 12-17 years old: 87.3 ± 15.4, <i>P</i> = .03). Pediatric patients did not have a significantly higher likelihood (odds ratio = 1.1, 95% confidence interval: 0.8-1.6, <i>P</i> > .05) of reporting HI-SCORES compared to adults after covariate adjustment.</p><p><strong>Conclusion: </strong>There was no significant difference in patient satisfaction scores for providers who treat pediatric and adult patients utilizing the same facility and scheduling team.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"8 2","pages":"e141"},"PeriodicalIF":1.5,"publicationDate":"2024-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11066763/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140867845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Injection Laryngoplasty for Children with Dysphagia after Cardiac Surgery. 为心脏手术后吞咽困难的儿童进行注射喉成形术。
IF 1.5 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-04-30 eCollection Date: 2024-04-01 DOI: 10.1002/oto2.142
Derek Sheen, Thomas K Houser, Sofia E Olsson, Helene Dabbous, Yann-Fuu Kou, Romaine F Johnson, Stephen R Chorney

Objective: To determine whether injection laryngoplasty (IL) resolves thin liquid aspiration among children with unilateral vocal cord paralysis (UVCP) after cardiac surgery.

Study design: Retrospective case-control.

Setting: Tertiary children's hospital.

Methods: Consecutive children (<5 years) between 2012 and 2022 with UVCP after cardiac surgery were included. Resolution of thin liquid aspiration after IL versus observation was determined for children obtaining videofluoroscopic swallow studies (VFSS).

Results: A total of 32 children with left UVCP after cardiac surgery met inclusion. Initial surgeries were N = 9 (28%) patent ductus arteriosus ligations, N = 7 (22%) aortic arch surgeries, N = 9 (28%) surgeries for hypoplastic left heart syndrome, and N = 7 (22%) other cardiac surgeries. The mean age at initial surgery was 1.8 months (SD: 3.7). All children had a VFSS obtained after surgery that confirmed aspiration. There were 17 children that obtained an IL at 33.6 months (SD: 20.9) after cardiac surgery and 15 children observed without IL procedure. No surgical complications after IL were noted. The rate of aspiration resolution based on postoperative VFSS was N = 14 (82%) for the IL group and N = 9 (60%) for the control group P = .24. Documented VFSS aspiration resolution after cardiac surgery occurred by 9.6 months (SD: 10.0) in the observation group and 47.4 months (SD: 24.1) in the IL group (P < .001).

Conclusion: IL can help treat aspiration in children with UVCP after cardiac surgery but the benefit beyond observation remains unclear. Future studies should continue to explore the utility for IL in managing dysphagia in this pediatric population.

研究目的研究设计:回顾性病例对照:研究设计:回顾性病例对照:研究设计:回顾性病例对照:方法:连续收治患儿(结果:共有 32 名左侧声带麻痹患儿接受了心脏手术):结果:共有32名心脏手术后左侧UVCP患儿符合纳入条件。初次手术包括N=9(28%)次动脉导管未闭结扎手术、N=7(22%)次主动脉弓手术、N=9(28%)次左心功能不全综合征手术以及N=7(22%)次其他心脏手术。首次手术的平均年龄为 1.8 个月(标清:3.7)。所有患儿均在术后获得了确认吸入的 VFSS。17名患儿在心脏手术后33.6个月(SD:20.9)时进行了IL,15名患儿未进行IL手术。IL术后未发现手术并发症。根据术后 VFSS,IL 组吸入缓解率为 N = 14(82%),对照组为 N = 9(60%),P = .24。观察组在心脏手术后 9.6 个月(SD:10.0)内 VFSS 吸入症状明显缓解,IL 组在 47.4 个月(SD:24.1)内 VFSS 吸入症状明显缓解:IL 可帮助治疗心脏手术后 UVCP 患儿的吸入,但观察之外的益处仍不明确。未来的研究应继续探索 IL 在治疗此类儿童吞咽困难方面的作用。
{"title":"Injection Laryngoplasty for Children with Dysphagia after Cardiac Surgery.","authors":"Derek Sheen, Thomas K Houser, Sofia E Olsson, Helene Dabbous, Yann-Fuu Kou, Romaine F Johnson, Stephen R Chorney","doi":"10.1002/oto2.142","DOIUrl":"https://doi.org/10.1002/oto2.142","url":null,"abstract":"<p><strong>Objective: </strong>To determine whether injection laryngoplasty (IL) resolves thin liquid aspiration among children with unilateral vocal cord paralysis (UVCP) after cardiac surgery.</p><p><strong>Study design: </strong>Retrospective case-control.</p><p><strong>Setting: </strong>Tertiary children's hospital.</p><p><strong>Methods: </strong>Consecutive children (<5 years) between 2012 and 2022 with UVCP after cardiac surgery were included. Resolution of thin liquid aspiration after IL versus observation was determined for children obtaining videofluoroscopic swallow studies (VFSS).</p><p><strong>Results: </strong>A total of 32 children with left UVCP after cardiac surgery met inclusion. Initial surgeries were N = 9 (28%) patent ductus arteriosus ligations, N = 7 (22%) aortic arch surgeries, N = 9 (28%) surgeries for hypoplastic left heart syndrome, and N = 7 (22%) other cardiac surgeries. The mean age at initial surgery was 1.8 months (SD: 3.7). All children had a VFSS obtained after surgery that confirmed aspiration. There were 17 children that obtained an IL at 33.6 months (SD: 20.9) after cardiac surgery and 15 children observed without IL procedure. No surgical complications after IL were noted. The rate of aspiration resolution based on postoperative VFSS was N = 14 (82%) for the IL group and N = 9 (60%) for the control group <i>P</i> = .24. Documented VFSS aspiration resolution after cardiac surgery occurred by 9.6 months (SD: 10.0) in the observation group and 47.4 months (SD: 24.1) in the IL group (<i>P</i> < .001).</p><p><strong>Conclusion: </strong>IL can help treat aspiration in children with UVCP after cardiac surgery but the benefit beyond observation remains unclear. Future studies should continue to explore the utility for IL in managing dysphagia in this pediatric population.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"8 2","pages":"e142"},"PeriodicalIF":1.5,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11058695/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140857427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inferior Turbinate Abscess from Bulb Suctioning in a Pediatric Patient. 一名儿科患者因球吸引起的下鼻甲脓肿
IF 1.5 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-04-26 eCollection Date: 2024-04-01 DOI: 10.1002/oto2.140
Caden D Duffy, Madeleine E Gallagher, Paul W Bauer, Maxie D Brewer
{"title":"Inferior Turbinate Abscess from Bulb Suctioning in a Pediatric Patient.","authors":"Caden D Duffy, Madeleine E Gallagher, Paul W Bauer, Maxie D Brewer","doi":"10.1002/oto2.140","DOIUrl":"https://doi.org/10.1002/oto2.140","url":null,"abstract":"","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"8 2","pages":"e140"},"PeriodicalIF":1.5,"publicationDate":"2024-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11048040/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140852281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of YouTube As A Source For Graves' Disease Information: Is High-Quality Guideline-Based Information Available? 对 YouTube 作为巴塞杜氏病信息来源的评估:是否有基于指南的高质量信息?
IF 1.5 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-03-19 eCollection Date: 2024-01-01 DOI: 10.1002/oto2.118
Oluwatobiloba Ayo-Ajibola, Ryan J Davis, Claire Theriault, Christopher Lamb, Deborah Choe, Matthew E Lin, Trevor E Angell, Daniel I Kwon

Objective: To understand the quality of informational Graves' disease (GD) videos on YouTube for treatment decision-making quality and inclusion of American Thyroid Association (ATA) treatment guidelines.

Study design: Cross-sectional cohort.

Setting: Informational YouTube videos with subject matter "Graves' Disease treatment."

Method: The top 50 videos based on our query were assessed using the DISCERN instrument. This validated algorithm discretely rates treatment-related information from excellent (≥4.5) to very poor (<1.9). Videos were also screened for ATA guideline inclusion. Descriptive statistics were used for cohort characterization. Univariate and multivariate linear regressions characterized factors associated with DISCERN scores. Significance was set at P < .05.

Results: The videos featured 57,513.43 views (SD = 162,579.25), 1054.70 likes (SD = 2329.77), and 168.80 comments (SD = 292.97). Most were patient education (52%) or patient experience (24%). A minority (40%) were made by thyroid specialists (endocrinologists, endocrine surgeons, or otolaryngologists). Under half did not mention all 3 treatment modalities (44%), and 54% did not mention any ATA recommendations. Overall, videos displayed poor reliability (mean = 2.26, SD = 0.67), treatment information quality (mean = 2.29, SD = 0.75), and overall video quality (mean = 2.47, SD = 1.07). Physician videos were associated with lower likes, views, and comments (P < .001) but higher DISCERN reliability (P = .015) and overall score (P = .019). Longer videos (P = .015), patient accounts (P = .013), and patient experience (P = .002) were associated with lower scores.

Conclusion: The most available GD treatment content on YouTube varies significantly in the quality of medical information. This may contribute to suboptimal disease understanding, especially for patients highly engaged with online health information sources.

目的:了解YouTube上巴塞杜氏病(GD)信息视频的质量,以确定治疗决策的质量,并纳入美国甲状腺协会(ATA)治疗指南:研究设计:横断面队列研究:横断面队列:YouTube上主题为 "巴塞杜氏病治疗 "的信息视频:使用 DISCERN 工具对我们查询的前 50 个视频进行评估。这种经过验证的算法将与治疗相关的信息从优秀(≥4.5)到极差(P)进行离散评分:视频的浏览量为 57513.43 次(SD = 162579.25),点赞数为 1054.70 次(SD = 2329.77),评论数为 168.80 次(SD = 292.97)。大部分是患者教育(52%)或患者体验(24%)。少数(40%)是由甲状腺专家(内分泌科医生、内分泌外科医生或耳鼻喉科医生)发表的。不到一半的视频没有提及所有三种治疗方式(44%),54%的视频没有提及任何ATA建议。总体而言,视频的可靠性(平均值 = 2.26,SD = 0.67)、治疗信息质量(平均值 = 2.29,SD = 0.75)和整体视频质量(平均值 = 2.47,SD = 1.07)均较差。医生视频的点讚数、浏览数和评论数(P P = .015)以及总评分(P = .019)均较低。较长的视频(P = .015)、患者账户(P = .013)和患者体验(P = .002)与较低的得分相关:结论:YouTube 上最常见的广东治疗内容在医疗信息质量方面差异很大。结论:YouTube 上最多的 GD 治疗内容在医疗信息质量方面存在很大差异,这可能会导致对疾病的理解不尽人意,尤其是对于高度使用在线健康信息来源的患者而言。
{"title":"Evaluation of YouTube As A Source For Graves' Disease Information: Is High-Quality Guideline-Based Information Available?","authors":"Oluwatobiloba Ayo-Ajibola, Ryan J Davis, Claire Theriault, Christopher Lamb, Deborah Choe, Matthew E Lin, Trevor E Angell, Daniel I Kwon","doi":"10.1002/oto2.118","DOIUrl":"https://doi.org/10.1002/oto2.118","url":null,"abstract":"<p><strong>Objective: </strong>To understand the quality of informational Graves' disease (GD) videos on YouTube for treatment decision-making quality and inclusion of American Thyroid Association (ATA) treatment guidelines.</p><p><strong>Study design: </strong>Cross-sectional cohort.</p><p><strong>Setting: </strong>Informational YouTube videos with subject matter \"Graves' Disease treatment.\"</p><p><strong>Method: </strong>The top 50 videos based on our query were assessed using the DISCERN instrument. This validated algorithm discretely rates treatment-related information from excellent (≥4.5) to very poor (<1.9). Videos were also screened for ATA guideline inclusion. Descriptive statistics were used for cohort characterization. Univariate and multivariate linear regressions characterized factors associated with DISCERN scores. Significance was set at <i>P</i> < .05.</p><p><strong>Results: </strong>The videos featured 57,513.43 views (SD = 162,579.25), 1054.70 likes (SD = 2329.77), and 168.80 comments (SD = 292.97). Most were patient education (52%) or patient experience (24%). A minority (40%) were made by thyroid specialists (endocrinologists, endocrine surgeons, or otolaryngologists). Under half did not mention all 3 treatment modalities (44%), and 54% did not mention any ATA recommendations. Overall, videos displayed poor reliability (mean = 2.26, SD = 0.67), treatment information quality (mean = 2.29, SD = 0.75), and overall video quality (mean = 2.47, SD = 1.07). Physician videos were associated with lower likes, views, and comments (<i>P</i> < .001) but higher DISCERN reliability (<i>P</i> = .015) and overall score (<i>P</i> = .019). Longer videos (<i>P</i> = .015), patient accounts (<i>P</i> = .013), and patient experience (<i>P</i> = .002) were associated with lower scores.</p><p><strong>Conclusion: </strong>The most available GD treatment content on YouTube varies significantly in the quality of medical information. This may contribute to suboptimal disease understanding, especially for patients highly engaged with online health information sources.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"8 1","pages":"e118"},"PeriodicalIF":1.5,"publicationDate":"2024-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10949313/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140175795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Otolaryngology Care Disparities in American Indian Populations. 美国印第安人的耳鼻喉科护理差异。
IF 1.5 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-03-15 eCollection Date: 2024-01-01 DOI: 10.1002/oto2.124
Alan W Wang, Evan A Patel, Nina Patel, Trevor A Poulson, Ashok A Jagasia

Our objectives were to quantify geographical disparities in otolaryngology care access with respect to American Indian (AI) populations and to identify gaps in care. Although increased incidence and mortality rates of ear, nose, and throat (ENT) conditions in AI populations are well documented, few studies address factors contributing to these differential outcomes. We conducted a cross-sectional study of US states with AI areas that either met the population threshold for the American Community Survey annual estimate or annual supplemental estimate. A 2-tailed t test was used to compare the geographic distribution of ENT providers practicing within AI areas against non-AI areas, showing a statistically significant difference (P < .001) in the concentration of providers (0.409 vs 2.233 providers per 100,000 patients). To our knowledge, this is the first study to explore geographic barriers contributing to AI disparities within otolaryngology.

我们的目标是量化美国印第安人(AI)在获得耳鼻喉科医疗服务方面的地域差异,并找出医疗服务中的差距。尽管耳鼻喉科(ENT)疾病在美国印第安人中的发病率和死亡率都有所提高,但很少有研究涉及导致这些差异结果的因素。我们对美国各州的人工智能地区进行了一项横断面研究,这些地区的人口数量达到了美国社区调查年度估计值或年度补充估计值的阈值。我们使用双尾 t 检验比较了在人工智能地区和非人工智能地区执业的耳鼻喉科医疗人员的地理分布,结果显示两者之间存在显著的统计学差异(P<0.05)。
{"title":"Otolaryngology Care Disparities in American Indian Populations.","authors":"Alan W Wang, Evan A Patel, Nina Patel, Trevor A Poulson, Ashok A Jagasia","doi":"10.1002/oto2.124","DOIUrl":"10.1002/oto2.124","url":null,"abstract":"<p><p>Our objectives were to quantify geographical disparities in otolaryngology care access with respect to American Indian (AI) populations and to identify gaps in care. Although increased incidence and mortality rates of ear, nose, and throat (ENT) conditions in AI populations are well documented, few studies address factors contributing to these differential outcomes. We conducted a cross-sectional study of US states with AI areas that either met the population threshold for the American Community Survey annual estimate or annual supplemental estimate. A 2-tailed <i>t</i> test was used to compare the geographic distribution of ENT providers practicing within AI areas against non-AI areas, showing a statistically significant difference (<i>P</i> < .001) in the concentration of providers (0.409 vs 2.233 providers per 100,000 patients). To our knowledge, this is the first study to explore geographic barriers contributing to AI disparities within otolaryngology.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"8 1","pages":"e124"},"PeriodicalIF":1.5,"publicationDate":"2024-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10941493/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140143932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends in Management of Ménière Disease: A TriNetX Network Database Analysis. 梅尼埃病管理趋势:TriNetX网络数据库分析
IF 1.5 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-03-14 eCollection Date: 2024-01-01 DOI: 10.1002/oto2.123
Tyler J Gallagher, Meredith E Adams, Janet S Choi

This study investigated management practices for Meniere's disease (MD) and their temporal trends from 2008 to 2022 within the TriNetX network database. Study cohort included adult patients (≥18 years) with the diagnosis of MD from TriNetX's multi-institutional medical records (n = 77,493). MD diagnosis and management were queried based on the international classification of diseases, tenth revision, current procedural terminology, and RXNorm codes. Temporal trends were analyzed using joinpoint regression. There was significant increase in rates of relevant medications prescribed within 12 months of MD diagnosis from 2008 to 2022 (annual percent change [APC]: 1.2 [95% confidence interval, CI: 0.4-1.9]). There were no significant changes in rate of intratympanic injection within 12 months of MD diagnosis (1.7 [95% CI: -1.1 to 4.5]). Rate of endolymphatic sac surgery and labyrinthectomy any time after MD diagnosis gradually decreased from 2008 to 2022 at APC of -8.1 (95% CI: -11.8 to -4.2) and -11.0 (95% CI: -14.0 to -7.7), respectively. Use of relevant medications has significantly increased during the early management of MD and the overall use of surgical treatments has decreased.

本研究调查了 TriNetX 网络数据库中梅尼埃病 (MD) 的管理方法及其 2008 年至 2022 年的时间趋势。研究队列包括 TriNetX 多机构医疗记录中诊断为 MD 的成年患者(≥18 岁)(n = 77,493 人)。MD 的诊断和管理是根据国际疾病分类第十次修订版、当前程序术语和 RXNorm 编码查询的。使用连接点回归分析了时间趋势。从 2008 年到 2022 年,MD 诊断后 12 个月内开具相关药物处方的比例明显增加(年百分比变化 [APC]:1.2 [95% 置信区间,CI:0.4-1.9])。在确诊 MD 后 12 个月内进行耳内注射的比例无明显变化(1.7 [95% 置信区间:-1.1 至 4.5])。从 2008 年到 2022 年,MD 诊断后随时进行内淋巴囊手术和迷路切除术的比例逐渐下降,APC 分别为-8.1(95% CI:-11.8 至-4.2)和-11.0(95% CI:-14.0 至-7.7)。在 MD 的早期治疗过程中,相关药物的使用明显增加,而手术治疗的总体使用有所减少。
{"title":"Trends in Management of Ménière Disease: A TriNetX Network Database Analysis.","authors":"Tyler J Gallagher, Meredith E Adams, Janet S Choi","doi":"10.1002/oto2.123","DOIUrl":"10.1002/oto2.123","url":null,"abstract":"<p><p>This study investigated management practices for Meniere's disease (MD) and their temporal trends from 2008 to 2022 within the TriNetX network database. Study cohort included adult patients (≥18 years) with the diagnosis of MD from TriNetX's multi-institutional medical records (n = 77,493). MD diagnosis and management were queried based on the international classification of diseases, tenth revision, current procedural terminology, and RXNorm codes. Temporal trends were analyzed using joinpoint regression. There was significant increase in rates of relevant medications prescribed within 12 months of MD diagnosis from 2008 to 2022 (annual percent change [APC]: 1.2 [95% confidence interval, CI: 0.4-1.9]). There were no significant changes in rate of intratympanic injection within 12 months of MD diagnosis (1.7 [95% CI: -1.1 to 4.5]). Rate of endolymphatic sac surgery and labyrinthectomy any time after MD diagnosis gradually decreased from 2008 to 2022 at APC of -8.1 (95% CI: -11.8 to -4.2) and -11.0 (95% CI: -14.0 to -7.7), respectively. Use of relevant medications has significantly increased during the early management of MD and the overall use of surgical treatments has decreased.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"8 1","pages":"e123"},"PeriodicalIF":1.5,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10938781/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140132258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Utility of Machine Learning Methods Using Regression Models for Diagnosing Eosinophilic Chronic Rhinosinusitis. 使用回归模型诊断嗜酸性粒细胞慢性鼻炎的机器学习方法的临床实用性。
IF 1.5 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-03-10 eCollection Date: 2024-01-01 DOI: 10.1002/oto2.122
Hiroatsu Hatsukawa, Masaaki Ishikawa

Objective: Machine learning methods using regression models can predict actual values of histological eosinophil count from blood eosinophil levels. Therefore, these methods might be useful for diagnosing eosinophilic chronic rhinosinusitis, but their utility still remains unclear. We compared 2 statistical approaches, and investigated the utility of machine learning methods for diagnosing eosinophilic chronic rhinosinusitis.

Study design: Retrospective study.

Setting: Medical center.

Methods: Data, including eosinophilic levels, obtained from blood and sinonasal samples of 264 patients with chronic rhinosinusitis (257 with and 57 without nasal polyps) were analyzed. We determined factors affecting histopathological eosinophil count in regression models. We also investigated optimal cutoff values for blood eosinophil percentages/absolute eosinophil counts (AECs) through receiver operating characteristic curves and machine-learning methods based on regression models. A histopathological eosinophil count ≥10/high-power field was defined as eosinophilic chronic rhinosinusitis.

Results: Blood eosinophil levels, nasal polyp presence, and comorbid asthma were factors affecting histopathological eosinophil count. Cutoffs between the 2 statistical approaches differed in the group with nasal polyps, but not in one without nasal polyps. Machine-learning methods identified blood eosinophil percentages ≥1% or AEC ≥100/μL as cut-offs for eosinophilic chronic rhinosinusitis with nasal polyps, while ≥6% or ≥400/μL for one without nasal polyps.

Conclusion: Cut-offs of blood eosinophil levels obtained by machine-learning methods might be useful when suspecting eosinophilic chronic rhinosinusitis prior to biopsy because of their ability to adjust covariates, dealing with overfitting, and predicting actual values of histological eosinophil count.

目的:使用回归模型的机器学习方法可以根据血液中的嗜酸性粒细胞水平预测组织学嗜酸性粒细胞计数的实际值。因此,这些方法可能有助于诊断嗜酸性粒细胞慢性鼻炎,但其效用仍不明确。我们比较了两种统计方法,并研究了机器学习方法在诊断嗜酸性粒细胞性慢性鼻炎方面的实用性:研究设计:回顾性研究:研究设计:回顾性研究:分析了从 264 名慢性鼻炎患者(257 名有鼻息肉,57 名无鼻息肉)的血液和鼻窦样本中获得的数据,包括嗜酸性粒细胞水平。我们在回归模型中确定了影响组织病理学嗜酸性粒细胞计数的因素。我们还通过接收者操作特征曲线和基于回归模型的机器学习方法研究了血液嗜酸性粒细胞百分比/绝对嗜酸性粒细胞计数(AECs)的最佳临界值。组织病理学嗜酸性粒细胞计数≥10/高倍视野被定义为嗜酸性粒细胞慢性鼻炎:结果:血液中的嗜酸性粒细胞水平、鼻息肉的存在和合并哮喘是影响组织病理学嗜酸性粒细胞计数的因素。在有鼻息肉的组别中,两种统计方法的临界值不同,而在无鼻息肉的组别中则没有差异。机器学习方法确定血液中嗜酸性粒细胞百分比≥1%或AEC≥100/μL为有鼻息肉的嗜酸性粒细胞慢性鼻窦炎的临界值,而≥6%或≥400/μL为无鼻息肉的慢性鼻窦炎的临界值:通过机器学习方法获得的血液嗜酸性粒细胞水平临界值在活检前怀疑嗜酸性粒细胞性慢性鼻炎时可能很有用,因为这些临界值能够调整协变量、处理过拟合以及预测组织学嗜酸性粒细胞计数的实际值。
{"title":"Clinical Utility of Machine Learning Methods Using Regression Models for Diagnosing Eosinophilic Chronic Rhinosinusitis.","authors":"Hiroatsu Hatsukawa, Masaaki Ishikawa","doi":"10.1002/oto2.122","DOIUrl":"10.1002/oto2.122","url":null,"abstract":"<p><strong>Objective: </strong>Machine learning methods using regression models can predict actual values of histological eosinophil count from blood eosinophil levels. Therefore, these methods might be useful for diagnosing eosinophilic chronic rhinosinusitis, but their utility still remains unclear. We compared 2 statistical approaches, and investigated the utility of machine learning methods for diagnosing eosinophilic chronic rhinosinusitis.</p><p><strong>Study design: </strong>Retrospective study.</p><p><strong>Setting: </strong>Medical center.</p><p><strong>Methods: </strong>Data, including eosinophilic levels, obtained from blood and sinonasal samples of 264 patients with chronic rhinosinusitis (257 with and 57 without nasal polyps) were analyzed. We determined factors affecting histopathological eosinophil count in regression models. We also investigated optimal cutoff values for blood eosinophil percentages/absolute eosinophil counts (AECs) through receiver operating characteristic curves and machine-learning methods based on regression models. A histopathological eosinophil count ≥10/high-power field was defined as eosinophilic chronic rhinosinusitis.</p><p><strong>Results: </strong>Blood eosinophil levels, nasal polyp presence, and comorbid asthma were factors affecting histopathological eosinophil count. Cutoffs between the 2 statistical approaches differed in the group with nasal polyps, but not in one without nasal polyps. Machine-learning methods identified blood eosinophil percentages ≥1% or AEC ≥100/μL as cut-offs for eosinophilic chronic rhinosinusitis with nasal polyps, while ≥6% or ≥400/μL for one without nasal polyps.</p><p><strong>Conclusion: </strong>Cut-offs of blood eosinophil levels obtained by machine-learning methods might be useful when suspecting eosinophilic chronic rhinosinusitis prior to biopsy because of their ability to adjust covariates, dealing with overfitting, and predicting actual values of histological eosinophil count.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"8 1","pages":"e122"},"PeriodicalIF":1.5,"publicationDate":"2024-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10924764/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140094404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Upper Respiratory Symptoms as Long COVID: Insight from a Multicenter Cohort Study. 上呼吸道症状作为长期 COVID:一项多中心队列研究的启示。
IF 1.5 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-03-03 eCollection Date: 2024-01-01 DOI: 10.1002/oto2.120
Masahiko Okada, Noriyuki Ishida, Sho Kanzaki, Ichiro Kawada, Kengo Nagashima, Hideki Terai, Gaku Hiruma, Ho Namkoong, Takanori Asakura, Katsunori Masaki, Keiko Ohgino, Jun Miyata, Shotaro Chubachi, Nobuhiro Kodama, Shunsuke Maeda, Satoshi Sakamoto, Masaki Okamoto, Yoji Nagasaki, Akira Umeda, Kazuya Miyagawa, Hisato Shimada, Kazuhiro Minami, Rie Hagiwara, Makoto Ishii, Yasunori Sato, Koichi Fukunaga

Objective: This study aimed to investigate the clinical features of long COVID cases presenting with upper respiratory symptoms, a topic not yet fully elucidated.

Study design: Prospective cohort study.

Setting: A multicenter study involving 26 medical facilities in Japan.

Methods: Inclusion criteria were patients aged ≥18 years old with a confirmed COVID-19 diagnosis via severe acute respiratory syndrome coronavirus 2 polymerase chain reaction or antigen testing, who were hospitalized at the participating medical facilities. Analyzing clinical information and patient-reported outcomes from 1009 patients were analyzed. The outcome measured the degree of initial symptoms for taste or olfactory disorders and assessed the likelihood of these symptoms persisting as long COVID, as well as the impact on quality of life if the upper respiratory symptoms persisted as long COVID.

Results: Patients with high albumin, low C-reactive protein, and low lactate dehydrogenase in laboratory tests tended to experience taste or olfactory disorders as part of long COVID. Those with severe initial symptoms had a higher risk of experiencing residual symptoms at 3 months, with an odds ratio of 2.933 (95% confidence interval [CI], 1.282-6.526) for taste disorders and 3.534 (95% CI, 1.382-9.009) for olfactory disorders. Presence of upper respiratory symptoms consistently resulted in lower quality of life scores.

Conclusion: The findings from this cohort study suggest that severe taste or olfactory disorders as early COVID-19 symptoms correlate with an increased likelihood of persistent symptoms in those disorders as long COVID.

研究目的本研究旨在调查伴有上呼吸道症状的长COVID病例的临床特征,这是一个尚未完全阐明的课题:研究设计:前瞻性队列研究:多中心研究,涉及日本 26 家医疗机构:纳入标准:通过严重急性呼吸系统综合征冠状病毒 2 聚合酶链反应或抗原检测确诊为 COVID-19 的≥18 岁患者,并在参与研究的医疗机构住院治疗。对 1009 名患者的临床信息和患者报告结果进行了分析。结果测量了味觉或嗅觉障碍初始症状的程度,评估了这些症状持续长时间COVID的可能性,以及如果上呼吸道症状持续长时间COVID对生活质量的影响:结果:实验室检测中白蛋白高、C反应蛋白低和乳酸脱氢酶低的患者在长期COVID中往往会出现味觉或嗅觉障碍。初始症状严重者在 3 个月后出现残留症状的风险更高,味觉障碍的几率比为 2.933(95% 置信区间 [CI],1.282-6.526),嗅觉障碍的几率比为 3.534(95% 置信区间,1.382-9.009)。出现上呼吸道症状会导致生活质量评分降低:这项队列研究的结果表明,严重的味觉或嗅觉障碍作为 COVID-19 的早期症状与这些障碍作为长期 COVID 的持续症状的可能性相关。
{"title":"Upper Respiratory Symptoms as Long COVID: Insight from a Multicenter Cohort Study.","authors":"Masahiko Okada, Noriyuki Ishida, Sho Kanzaki, Ichiro Kawada, Kengo Nagashima, Hideki Terai, Gaku Hiruma, Ho Namkoong, Takanori Asakura, Katsunori Masaki, Keiko Ohgino, Jun Miyata, Shotaro Chubachi, Nobuhiro Kodama, Shunsuke Maeda, Satoshi Sakamoto, Masaki Okamoto, Yoji Nagasaki, Akira Umeda, Kazuya Miyagawa, Hisato Shimada, Kazuhiro Minami, Rie Hagiwara, Makoto Ishii, Yasunori Sato, Koichi Fukunaga","doi":"10.1002/oto2.120","DOIUrl":"10.1002/oto2.120","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to investigate the clinical features of long COVID cases presenting with upper respiratory symptoms, a topic not yet fully elucidated.</p><p><strong>Study design: </strong>Prospective cohort study.</p><p><strong>Setting: </strong>A multicenter study involving 26 medical facilities in Japan.</p><p><strong>Methods: </strong>Inclusion criteria were patients aged ≥18 years old with a confirmed COVID-19 diagnosis via severe acute respiratory syndrome coronavirus 2 polymerase chain reaction or antigen testing, who were hospitalized at the participating medical facilities. Analyzing clinical information and patient-reported outcomes from 1009 patients were analyzed. The outcome measured the degree of initial symptoms for taste or olfactory disorders and assessed the likelihood of these symptoms persisting as long COVID, as well as the impact on quality of life if the upper respiratory symptoms persisted as long COVID.</p><p><strong>Results: </strong>Patients with high albumin, low C-reactive protein, and low lactate dehydrogenase in laboratory tests tended to experience taste or olfactory disorders as part of long COVID. Those with severe initial symptoms had a higher risk of experiencing residual symptoms at 3 months, with an odds ratio of 2.933 (95% confidence interval [CI], 1.282-6.526) for taste disorders and 3.534 (95% CI, 1.382-9.009) for olfactory disorders. Presence of upper respiratory symptoms consistently resulted in lower quality of life scores.</p><p><strong>Conclusion: </strong>The findings from this cohort study suggest that severe taste or olfactory disorders as early COVID-19 symptoms correlate with an increased likelihood of persistent symptoms in those disorders as long COVID.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"8 1","pages":"e120"},"PeriodicalIF":1.5,"publicationDate":"2024-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10909391/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140022289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peronea Magna: An Important Anatomic Variant Impacting Fibula-Free Flap Reconstruction. 腓骨尾骨:影响无腓骨皮瓣重建的重要解剖变异。
IF 1.5 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-02-28 eCollection Date: 2024-01-01 DOI: 10.1002/oto2.121
Wasiq Nadeem, Jay K Ferrell, Christine B Taylor
{"title":"Peronea Magna: An Important Anatomic Variant Impacting Fibula-Free Flap Reconstruction.","authors":"Wasiq Nadeem, Jay K Ferrell, Christine B Taylor","doi":"10.1002/oto2.121","DOIUrl":"10.1002/oto2.121","url":null,"abstract":"","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"8 1","pages":"e121"},"PeriodicalIF":1.5,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10900915/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139990834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Sleep Characteristics with Tinnitus and Hearing Loss. 睡眠特征与耳鸣和听力损失的关系
IF 1.5 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-02-28 eCollection Date: 2024-01-01 DOI: 10.1002/oto2.117
Matthew Awad, Ibrahim Abdalla, Sebastian M Jara, Tina C Huang, Meredith E Adams, Janet S Choi

Objective: The impact of poor sleep on tinnitus has been mainly attributed to central processes. There is an association between sleep disorders and hearing loss, but whether hearing levels mediate the association between sleep disorders and tinnitus is unknown. This study investigates the association between sleep characteristics, tinnitus, and hearing loss.

Study design: Cross-sectional.

Setting: National Health and Nutrition Examination Survey (NHANES).

Methods: Study cohort includes 9693 adults (≥20 years) from the NHANES 2005 to 2018 who completed audiometric testing and questionnaires on tinnitus and sleep characteristics. Multivariable regression analyses were performed to quantify associations between sleep characteristics, tinnitus, and hearing loss.

Results: In this cohort, 29% (95% confidence interval [CI]: 28%-31%) reported trouble sleeping and 9% (95% CI: 8%-10%) reported being diagnosed with sleep disorders. Negative sleep characteristics (less hours of sleep, diagnosis of a sleep disorder, trouble sleeping, or OSA symptoms) were not associated with audiometry-measured hearing loss in multivariable models adjusted for demographics and comorbidities but were significantly associated with bothersome tinnitus. This association remained significant without substantial attenuation in multivariable models additionally adjusting for hearing levels: sleeping <8 h/day (vs ≥8) (odds ratio [OR]: 1.28 [95% CI: 1.08-1.52]), trouble sleeping (OR: 1.78 [95% CI: 1.45-2.19]), diagnosis of sleep disorders (OR: 1.57 [95% CI: 1.14-2.15]), and report of OSA symptoms (OR: 1.42 [95% CI: 1.08-1.88]).

Conclusion: Negative sleep characteristics were associated with tinnitus while there was no clinically meaningful association between sleep and hearing loss. Our findings suggest that the relationship between poor sleep and tinnitus is likely contributed by central processes without a major role of mediation via the peripheral auditory system.

目的:睡眠不足对耳鸣的影响主要归因于中枢过程。睡眠障碍与听力损失之间存在关联,但听力水平是否会介导睡眠障碍与耳鸣之间的关联尚不清楚。本研究调查了睡眠特征、耳鸣和听力损失之间的关系:研究设计:横断面:美国国家健康与营养调查(NHANES):研究队列包括2005年至2018年NHANES中的9693名成年人(≥20岁),他们完成了听力测试和有关耳鸣和睡眠特征的问卷调查。研究人员进行了多变量回归分析,以量化睡眠特征、耳鸣和听力损失之间的关联:在这组人群中,29%(95% 置信区间 [CI]:28%-31%)的人表示有睡眠问题,9%(95% 置信区间:8%-10%)的人表示被诊断患有睡眠障碍。在调整了人口统计学和合并症的多变量模型中,负面睡眠特征(睡眠时间少、被诊断患有睡眠障碍、睡眠困难或 OSA 症状)与听力测定法测量的听力损失无关,但与令人烦恼的耳鸣显著相关。在对听力水平进行额外调整的多变量模型中,这种相关性仍然显著,且没有大幅衰减:不良睡眠特征与耳鸣有关,而睡眠与听力损失之间没有临床意义上的关联。我们的研究结果表明,睡眠质量差与耳鸣之间的关系很可能是由中枢过程造成的,而外周听觉系统并没有发挥重要的中介作用。
{"title":"Association of Sleep Characteristics with Tinnitus and Hearing Loss.","authors":"Matthew Awad, Ibrahim Abdalla, Sebastian M Jara, Tina C Huang, Meredith E Adams, Janet S Choi","doi":"10.1002/oto2.117","DOIUrl":"10.1002/oto2.117","url":null,"abstract":"<p><strong>Objective: </strong>The impact of poor sleep on tinnitus has been mainly attributed to central processes. There is an association between sleep disorders and hearing loss, but whether hearing levels mediate the association between sleep disorders and tinnitus is unknown. This study investigates the association between sleep characteristics, tinnitus, and hearing loss.</p><p><strong>Study design: </strong>Cross-sectional.</p><p><strong>Setting: </strong>National Health and Nutrition Examination Survey (NHANES).</p><p><strong>Methods: </strong>Study cohort includes 9693 adults (≥20 years) from the NHANES 2005 to 2018 who completed audiometric testing and questionnaires on tinnitus and sleep characteristics. Multivariable regression analyses were performed to quantify associations between sleep characteristics, tinnitus, and hearing loss.</p><p><strong>Results: </strong>In this cohort, 29% (95% confidence interval [CI]: 28%-31%) reported trouble sleeping and 9% (95% CI: 8%-10%) reported being diagnosed with sleep disorders. Negative sleep characteristics (less hours of sleep, diagnosis of a sleep disorder, trouble sleeping, or OSA symptoms) were not associated with audiometry-measured hearing loss in multivariable models adjusted for demographics and comorbidities but were significantly associated with bothersome tinnitus. This association remained significant without substantial attenuation in multivariable models additionally adjusting for hearing levels: sleeping <8 h/day (vs ≥8) (odds ratio [OR]: 1.28 [95% CI: 1.08-1.52]), trouble sleeping (OR: 1.78 [95% CI: 1.45-2.19]), diagnosis of sleep disorders (OR: 1.57 [95% CI: 1.14-2.15]), and report of OSA symptoms (OR: 1.42 [95% CI: 1.08-1.88]).</p><p><strong>Conclusion: </strong>Negative sleep characteristics were associated with tinnitus while there was no clinically meaningful association between sleep and hearing loss. Our findings suggest that the relationship between poor sleep and tinnitus is likely contributed by central processes without a major role of mediation via the peripheral auditory system.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"8 1","pages":"e117"},"PeriodicalIF":1.5,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10900921/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139990833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
OTO Open
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1